Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria flag Bulgaria · Delayed Price · Currency is BGN · Price in EUR
9.55
+0.20 (2.14%)
At close: Apr 30, 2026

BUL:THQM Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
34.6932.7327.2424.822.0621.7
Other Revenue
-0.04-----
34.6532.7327.2424.822.0621.7
Revenue Growth (YoY)
21.07%20.17%9.83%12.46%1.65%5.84%
Cost of Revenue
10.459.7910.4217.156.5515.73
Gross Profit
24.2122.9416.827.6615.515.97
Selling, General & Admin
17.9517.5512.683.7512.262.9
Other Operating Expenses
0.370.340.150.42-0.140.33
Operating Expenses
19.8419.3714.125.6113.955.22
Operating Income
4.373.582.72.051.560.75
Interest Expense
-0.22-0.23-0.3-0.28-0.14-0.14
Interest & Investment Income
0.30.30.240.240.240.23
Currency Exchange Gain (Loss)
---0.04-0-0.03-0.03
Other Non Operating Income (Expenses)
-0.02-0.02-0.02-0.02-0.02-0.01
EBT Excluding Unusual Items
4.423.632.581.981.60.8
Pretax Income
4.423.632.581.981.60.8
Income Tax Expense
0.350.340.280.240.170.09
Net Income
4.073.292.31.741.430.71
Net Income to Common
4.073.292.31.741.430.71
Net Income Growth
53.39%42.87%32.46%21.89%99.78%226.30%
Shares Outstanding (Basic)
919696939393
Shares Outstanding (Diluted)
919696939393
Shares Change (YoY)
-9.31%-3.38%--38.72%
EPS (Basic)
0.040.030.020.020.020.01
EPS (Diluted)
0.040.030.020.020.020.01
EPS Growth
69.14%42.87%28.13%21.90%99.78%135.25%
Free Cash Flow
1.631.270.610.490.450.23
Free Cash Flow Per Share
0.020.010.010.010.010.00
Gross Margin
69.86%70.08%61.76%30.87%70.31%27.49%
Operating Margin
12.60%10.92%9.92%8.26%7.06%3.43%
Profit Margin
11.75%10.05%8.45%7.01%6.47%3.29%
Free Cash Flow Margin
4.69%3.87%2.25%1.97%2.04%1.06%
EBITDA
5.644.813.983.483.262.71
EBITDA Margin
16.28%14.68%14.62%14.04%14.78%12.50%
D&A For EBITDA
1.281.231.281.431.71.97
EBIT
4.373.582.72.051.560.75
EBIT Margin
12.60%10.92%9.92%8.26%7.06%3.43%
Effective Tax Rate
7.95%9.31%10.73%12.14%10.92%10.74%
Revenue as Reported
34.6832.76---21.76
Source: S&P Global Market Intelligence. Standard template. Financial Sources.